Medicine is being stockpiled in the United Kingdom in preparation for a messy Brexit. French drugmaker Sanofi and its Swiss rival Novartis confirmed Wednesday that they're stockpiling treatments to prepare for a scenario where Britain crashes out of the European Union without a Brexit deal. "Sanofi is confident that its contingency plans will ensure that people in the United Kingdom can access the treatments they need," Fry said in a statement. To prepare for that, it's shifting some jobs in testing, quality control and labeling from the United Kingdom to other European Union countries. UK pharmaceutical company GlaxoSmithKline (GLAXF) also said it would boost its operations in the rest of the European Union ahead of Brexit.

Source: CNN August 01, 2018 13:24 UTC